Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
NCT: NCT04502316 · TERMINATED
広告
NCT識別子NCT04502316
ステータスTERMINATED
開始日2020-06-26
完了2026-06-30
SponsorCVRx, Inc. (INDUSTRY)
First posted
Last updated
概要
The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。